MedTrace Logo

IVUS Guided PCI for CKD to Reduce CI-AKI

NCT05913362 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2023-06-22

No results posted yet for this study

Summary

Patients with Chronic kidney disease are most vulnerable to contrast induced nephropathy after Percutaneous coronary intervention, intravascular ultrasound guidance can be used to safely guide the procedure to reduce the contrast usage, this randomized trial is design to test the hypothesis that IVUS based ultra-low contrast PCI is feasible and can reduce the contrast induced nephropathy.

Conditions

Interventions

BEHAVIORAL

IVUS based ultralow contrast PCI

IVUS based ultralow contrast PCI

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Zhongnan Hospital

    collaborator OTHER

  • Zhongshan People's Hospital, Guangdong, China

    collaborator OTHER

  • The Sixth People's Hospital of Zhengzhou

    collaborator OTHER

  • China-Japan Union Hospital, Jilin University

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER

  • Jilin University

    lead OTHER

Principal Investigators

  • Mingyou Zhang · Jilin University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-10-01
Completion
2025-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913362 on ClinicalTrials.gov